2,5-Dimethoxyamphetamine
| Clinical data | |
|---|---|
| Other names | 2,5-DMA; 2,5-Dimethoxy-α-methylphenethylamine; DMA; DMA-4; DOH; NSC-367445 | 
| Routes of administration | Oral | 
| Drug class | Serotonin 5-HT2A receptor agonist | 
| Pharmacokinetic data | |
| Duration of action | 6–8 hours | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.018.673 | 
| Chemical and physical data | |
| Formula | C11H17NO2 | 
| Molar mass | 195.262 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
2,5-Dimethoxyamphetamine (2,5-DMA), also known as DMA-4 or as DOH, is a drug of the phenethylamine and amphetamine families. It is one of the dimethoxyamphetamine (DMA) series of positional isomers. The drug is notable in being the parent compound of the DOx (4-substituted-2,5-dimethoxyamphetamine) series of drugs.